Wellthy Therapeutics uses Ambee's air quality data to power personalized care

Wellthy Therapeutics builds digital therapeutics for chronic respiratory conditions. To help patients and clinicians manage asthma and allergy triggers, Wellthy needed environmental data precise enough to inform individual treatment decisions, not just general air quality trends.Wellthy integrated Ambee's air quality dataset into its Asthma Weather Insights feature. Patients get present and historical exposure data for air quality, humidity, temperature, and pollen, each translated into a clear risk level rather than a raw number. With patient authorization, that same exposure history reaches the treating physician, supporting more informed diagnosis and care planning.

Key insights:

• Four datasets, one risk picture. Air quality, humidity, temperature, and pollen combine into a single, categorized view patients can act on immediately.
• Built for chronic condition management. The data supports ongoing care decisions, not a one-time diagnosis or a seasonal spike.
• Reaches both patient and physician. The same exposure history informs self-management and, when authorized, clinical decision-making.
• Hyperlocal by design. Patients see conditions specific to their own location, not a regional or national average.

Read the case study to learn more about the partnership and how it can benefit both healthcare partners and patients.